Meeting
2019 ASCO Annual Meeting
Comparative genomic profiling from tumor tissue and circulating tumor DNA (ctDNA) in 111 patients (Pts) with metastatic clear cell renal cell carcinoma.
Authors
Ritesh Kotecha
Memorial Sloan Kettering Cancer Center, New York, NY
Ritesh Kotecha , Erika Gedvilaite , Samuel J. Murray , Robert J. Motzer , Dana Tsui , Martin Henner Voss
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 4565)
DOI
10.1200/JCO.2019.37.15_suppl.4565
Abstract #
4565
Poster Bd #
391
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Tumor genomic landscape in younger compared to older patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).
First Author: Nishita Tripathi
Poster
2017 Genitourinary Cancers Symposium
Genomic profiling of nephrectomy and metastatic sites in patients with advanced clear cell renal cell carcinoma (RCC).
First Author: Guillermo de Velasco
Poster
2024 ASCO Annual Meeting
Matched tissue and circulating tumor DNA (ctDNA) analysis in renal cell carcinoma (RCC): Results from a multimodal real-world database.
First Author: Rana R. McKay
Poster
2018 ASCO Annual Meeting
PBRM1 mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.
First Author: Gennady Bratslavsky